United States · FDA National Drug Code directory
Claritin Reditabs
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11523-7157_4536fe84-5b46-ca4c-e063-6394a90ad03a
- Product NDC
- 11523-7157
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Loratadine
- Labeler
- Bayer Healthcare LLC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20021127
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (11523-7157-2) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 11523-7157-2
- 3 BLISTER PACK in 1 CARTON (11523-7157-3) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 11523-7157-3
- 2 BLISTER PACK in 1 CARTON (11523-7157-4) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 11523-7157-4
- 4 BLISTER PACK in 1 CARTON (11523-7157-7) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 11523-7157-7
- 5 BLISTER PACK in 1 CARTON (11523-7157-8) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 11523-7157-8
- 7 BLISTER PACK in 1 CARTON (11523-7157-9) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 11523-7157-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →